Spectrum Pharma (SPPI) Tops Q4 EPS by 17c

Spectrum Pharma (NASDAQ: SPPI) reported Q4 EPS of ($0.10), $0.17 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $32.2 million versus the consensus estimate of $31.13 million.

For earnings history and earnings-related data on Spectrum Pharma (SPPI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• SanDisk upgraded at JPMorgan after investor day; shares climb